+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Alopecia Treatment Market by Disease Type, Route of Administration, Gender, Treatment Option, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5305520
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Alopecia Treatment Market grew from USD 4.85 billion in 2023 to USD 5.27 billion in 2024. It is expected to continue growing at a CAGR of 8.89%, reaching USD 8.81 billion by 2030.

The alopecia treatment market encompasses a broad range of therapeutic approaches and products aimed at addressing various forms of hair loss, including but not limited to androgenetic alopecia, alopecia areata, and telogen effluvium. The necessity of such treatments arises from the psychological and social impact of hair loss, making effective therapies crucial for improving patient quality of life. Applications span multiple therapeutic areas including topical treatments, oral medications, injectable therapies, and surgical interventions like hair transplantation. End-user scope primarily includes dermatology clinics, hospitals, and cosmetic stores. Market growth is driven by the increasing prevalence of alopecia due to genetic factors, autoimmune disorders, and lifestyle changes, along with rising consumer awareness and acceptance of aesthetic and medical dermatology treatments. The market is witnessing potential opportunities in personalized medicine, stem cell research, and the development of novel drug delivery systems. To capitalize on these, companies could focus on enhancing R&D capabilities, forming strategic partnerships for innovation, and exploring emerging markets with high unmet needs. Despite these growth enablers, challenges persist, including high treatment costs, variable patient response rates, and limited insurance coverage, which could hinder market expansion. Furthermore, regulatory hurdles related to the approval of new therapies may delay product launch timelines. To stay competitive, businesses should invest in genetically tailored solutions and integrate digital health technologies for patient monitoring and engagement. The innovation frontier can also benefit from breakthroughs in genome editing technologies such as CRISPR, which holds promise for more targeted treatments. Overall, the alopecia treatment market is dynamic and innovation-driven, requiring stakeholders to remain agile and responsive to rapidly evolving scientific advancements and consumer demands.

Understanding Market Dynamics in the Alopecia Treatment Market

The Alopecia Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing incidence of androgenetic alopecia and alopecia areata diseases
    • Growing awareness about hair loss and transplantation
    • Rise in income levels and increased healthcare spending
  • Market Restraints
    • Lack of reimbursement policies for alopecia treatments
  • Market Opportunities
    • Emergence of new alopecia areata treatments and therapeutics
    • Rising investments and expansion of hair transplant clinics
  • Market Challenges
    • Issues associated with efficacy and side-effects related to some hair loss treatment therapies

Exploring Porter’s Five Forces for the Alopecia Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Alopecia Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Alopecia Treatment Market

External macro-environmental factors deeply influence the performance of the Alopecia Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Alopecia Treatment Market

The Alopecia Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Alopecia Treatment Market

The Alopecia Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Alopecia Treatment Market

The Alopecia Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Alopecia Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aclaris Therapeutics, Inc., AnaptysBio Inc., Apira Science, Inc., Apple Therapeutics Private Limited, Arcutis Biotherapeutics, Inc., Biocon Limited, Cipla, Inc., Daiichi Sankyo Inc., DR. KURT WOLFF GMBH & CO. KG, Dr. Reddy's Laboratories Ltd, Eli Lilly and Company, Fagron NV, Follica, Inc., HCell Inc., iRestore Hair Growth System, KNOW Bio LLC, Merck & Co., Pfizer Inc., Regeneron Pharmaceuticals, Inc., RepliCel Life Sciences Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Transitions Hair Pty Ltd., and Viviscal.

Market Segmentation & Coverage

This research report categorizes the Alopecia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Disease Type
    • Alopecia Areata
    • Alopecia Totalis
    • Alopecia Universalis
    • Androgenetic Alopecia
    • Cicatricial Alopecia
    • Traction Alopecia
  • Route of Administration
    • Injectable
    • Oral
    • Topical
  • Gender
    • Female
    • Male
  • Treatment Option
    • Cosmetic Treatment
      • Hair Fiber Powders
      • Scalp Micropigmentation
    • Medical Treatment
      • Anthralin
      • Corticosteroid
      • JAK Inhibitors
      • Methotrexate
      • Topical Immunotherapy
    • Surgical Treatment
      • Follicular Unit Extraction
      • Hair Transplant Surgery
      • Scalp Reduction Treatment
  • End User
    • Dermatology Clinics
    • Homecare Setting
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of androgenetic alopecia and alopecia areata diseases
5.1.1.2. Growing awareness about hair loss and transplantation
5.1.1.3. Rise in income levels and increased healthcare spending
5.1.2. Restraints
5.1.2.1. Lack of reimbursement policies for alopecia treatments
5.1.3. Opportunities
5.1.3.1. Emergence of new alopecia areata treatments and therapeutics
5.1.3.2. Rising investments and expansion of hair transplant clinics
5.1.4. Challenges
5.1.4.1. Issues associated with efficacy and side-effects related to some hair loss treatment therapies
5.2. Market Segmentation Analysis
5.2.1. Disease Type: Growing need for effective treatments for alopecia universalis and alopecia totalis
5.2.2. End User: homecare treatments owing to their Convenience and cost-effectiveness
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Alopecia Treatment Market, by Disease Type
6.1. Introduction
6.2. Alopecia Areata
6.3. Alopecia Totalis
6.4. Alopecia Universalis
6.5. Androgenetic Alopecia
6.6. Cicatricial Alopecia
6.7. Traction Alopecia
7. Alopecia Treatment Market, by Route of Administration
7.1. Introduction
7.2. Injectable
7.3. Oral
7.4. Topical
8. Alopecia Treatment Market, by Gender
8.1. Introduction
8.2. Female
8.3. Male
9. Alopecia Treatment Market, by Treatment Option
9.1. Introduction
9.2. Cosmetic Treatment
9.2.1. Hair Fiber Powders
9.2.2. Scalp Micropigmentation
9.3. Medical Treatment
9.3.1. Anthralin
9.3.2. Corticosteroid
9.3.3. JAK Inhibitors
9.3.4. Methotrexate
9.3.5. Topical Immunotherapy
9.4. Surgical Treatment
9.4.1. Follicular Unit Extraction
9.4.2. Hair Transplant Surgery
9.4.3. Scalp Reduction Treatment
10. Alopecia Treatment Market, by End User
10.1. Introduction
10.2. Dermatology Clinics
10.3. Homecare Setting
11. Americas Alopecia Treatment Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Alopecia Treatment Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Alopecia Treatment Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Lilly's Olumiant (Baricitinib) Authorized in Canada for Severe Alopecia Areata Treatment
14.3.2. HopeMed Advances Phase II Clinical Trials for Innovative Androgenetic Alopecia Treatment
14.3.3. FDA Approves Pfizer's LITFULO (Ritlecitinib) for Severe Alopecia Treatment
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ALOPECIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. ALOPECIA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ALOPECIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ALOPECIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. ALOPECIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ALOPECIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ALOPECIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ALOPECIA TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TOTALIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA UNIVERSALIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY CICATRICIAL ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TRACTION ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HAIR FIBER POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SCALP MICROPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ANTHRALIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY JAK INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY FOLLICULAR UNIT EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HAIR TRANSPLANT SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SCALP REDUCTION TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HOMECARE SETTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. CANADA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 69. CANADA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 70. CANADA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 71. CANADA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. CANADA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. CANADA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 80. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. CHINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 109. CHINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. CHINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 111. CHINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 112. CHINA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 113. CHINA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 114. CHINA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 115. CHINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. INDIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 117. INDIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. INDIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 119. INDIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 120. INDIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 121. INDIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. INDIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 123. INDIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 131. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 133. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 135. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 136. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 139. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 147. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 155. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 162. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 163. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 171. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 177. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 179. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 181. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 183. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 184. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 185. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 186. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 187. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 195. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 205. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 206. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 208. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 209. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 210. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 211. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 212. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 216. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 217. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 218. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 219. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 220. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 222. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 224. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 225. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 226. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 227. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 228. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 230. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 232. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 233. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 234. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 235. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 236. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 238. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 239. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 240. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 241. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 242. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 243. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 244. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 251. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 252. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. ITALY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 254. ITALY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 255. ITALY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 256. ITALY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 257. ITALY ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 258. ITALY ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 259. ITALY ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 260. ITALY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 276. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 278. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 280. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 281. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 282. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 283. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 284. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. POLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 286. POLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. POLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 288. POLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 289. POLAND ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 290. POLAND ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 291. POLAND ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 292. POLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. QATAR ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 294. QATAR ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 295. QATAR ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 296. QATAR ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 297. QATAR ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 298. QATAR ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 299. QATAR ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 300. QATAR ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 308. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 324. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 326. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 327. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 328. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 329. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 330. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 331. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 332. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 333. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 336. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
TABLE 337. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
TABLE 338. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 339. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 340. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 341. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 342. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE

Companies Mentioned

The leading players in the Alopecia Treatment Market, which are profiled in this report, include:
  • AbbVie Inc.
  • Aclaris Therapeutics, Inc.
  • AnaptysBio Inc.
  • Apira Science, Inc.
  • Apple Therapeutics Private Limited
  • Arcutis Biotherapeutics, Inc.
  • Biocon Limited
  • Cipla, Inc.
  • Daiichi Sankyo Inc.
  • DR. KURT WOLFF GMBH & CO. KG
  • Dr. Reddy's Laboratories Ltd
  • Eli Lilly and Company
  • Fagron NV
  • Follica, Inc.
  • HCell Inc.
  • iRestore Hair Growth System
  • KNOW Bio LLC
  • Merck & Co.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • RepliCel Life Sciences Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd
  • Transitions Hair Pty Ltd.
  • Viviscal

Methodology

Loading
LOADING...

Table Information